Aplicación de la tecnología de impresión en 3D para la formulación farmacéutica de flavonoides.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 247, doi. 10.30827/ars.v66i2.31923
- By:
- Publication type:
- Article
Works matching IS 00042927 AND DT 2025 AND VI 66 AND IP 2
Results: 11
1
2
Gradual dose reduction versus abrupt deprescription of antipsychotic in patients with dementia: A systematic review.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 233, doi. 10.30827/ars.v66i2.31635
- By:
- Publication type:
- Article
3
Curcumin and its derivatives as potential antiviral candidates against monkeypox (mpox): a review of computational studies.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 225, doi. 10.30827/ars.v66i2.32423
- By:
- Publication type:
- Article
4
Identificación y caracterización de eventos adversos asociados a la utilización de Cannabis: Revisión estructurada.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 210, doi. 10.30827/ars.v66i2.31894
- By:
- Publication type:
- Article
5
Foeniculum vulgare Miller en el tratamiento de la sintomatología asociada a la menopausia.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 198, doi. 10.30827/ars.v66i2.31647
- By:
- Publication type:
- Article
6
Bacterias resistentes a antibióticos en aguas superficiales de la región pampeana, Argentina.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 187, doi. 10.30827/ars.v66i1.31883
- By:
- Publication type:
- Article
7
Topical Ethosomal Formulation of Alpha Arbutin: Dermatokinetic Study and In-vitro Evaluation.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 174, doi. 10.30827/ars.v66i2.31421
- By:
- Publication type:
- Article
8
Evaluation of the Probiotic Potential of Bacillus velezensis SNR14-4 Strain from Nile Tilapia Gills Using Genomic and In Vitro Approach.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 152, doi. 10.30827/ars.v66i2.31858
- By:
- Publication type:
- Article
9
Formulation, Development, and Evaluation of Flubiprofen Sustained Release Tablets Using a Quality-by-Design Approach.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 139, doi. 10.30827/ars.v66i2.31527
- By:
- Publication type:
- Article
10
Solubility Enhancement of Brexpiprazole for Schizophrenia using HPβ Cyclodextrin Ternary Complexation.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 126, doi. 10.30827/ars.v66i2.32043
- By:
- Publication type:
- Article
11
Inteligencia híbrida aplicada a los servicios profesionales farmacéuticos asistenciales: potenciando la inteligencia humana con las tecnologías avanzadas.
- Published in:
- Ars Pharmaceutica, 2025, v. 66, n. 2, p. 122, doi. 10.30827/ars.v66i2.33007
- By:
- Publication type:
- Article